维普中文期刊产品整合服务
24篇 您的检索式:作者名="Drake SL"
    题名 作者 年代 出处 被引量
1Sources of umami taste in Cheddar and Swiss cheeses显示文摘Drake SL Carnnchia Whetstine ME Drake MA 2007Journal of Food Science2007,72,6:1
2Targeting the PD-1/B7- HI(PD-L1) pathway to activate anti-tumor immunity 显示文摘Topalian SL Drake CG Pardoll DM 2012Cur- rent opinion in immunology2012,24,2:1
3Targeting the PD-1/B7-II1 ( PD-L1 ) pathway to activate anti-tumor immunity显示文摘Topalian SL Drake CG Pardoll DM 2012Curt Opin Immunol2012,24,2:1
4Targeting the PD-1/B7-H1 (PD-L1) pathway to activate anti-tumor immunity 显示文摘Topalian SL Drake CG Pardoll DM 2012Curr Opin Immunol2012,24,2:1
5Targeting the PD-1/ BT-H1 ( PILL1 ) pathway to activate anti-tumor immunity 显示文摘Topalian SL Drake CG Pardoll DM 2012Curr Opin Immunol2012,24,2:1
6Correlation of mannitol fermentation with virulence-associated genotypic characteristics in Vibrio vulnificus isolates from oysters and water samples in the Gulf of Mexico 显示文摘Drake SL Whitney B Levine JF 2010Foodborne Pathog Dis2010,7,1:1
7Immune check- point blockade: a common denominator approach to cancer therapy显示文摘Topalian SL Drake CG Pardo11 DM 2015Cancer Cell2015,27,4:1
8Immune checkpoint blockade: a common denominator approach to cancer therapy 显示文摘Topalian SL Drake CG Pardoll DM 2015Cancer Cell2015,27,4:1
9Targeting the PD-I/B7-H1 (PD-L1) pathway to activate anti-tumor immunity 显示文摘Topalian SL Drake CG Pardoll DM 2012Curt Opin Immunol2012,24,2:1
10Immune checkpoint blockade: a common denominator approach to cancer therapy显示文摘TOPALIAN SL DRAKE CG PARDOLL DM 2015Cancer Cell2015,27,4:1
11Immune checkpoint blockade: a common denominator approach to cancer therapy 显示文摘Topalian SL Drake CG Pardoll DM 2015Cancer Cell2015,27,4:1
12Targeting the PD-1/B7-H1 (PD-L1) pathway to activate anti-tumor immunity显示文摘Topalian SL Drake CG Pardoll DM 2012Curr Opin Immunol2012,24,2:1
13Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity 显示文摘Topalian SL Drake CG Pardoll DM 2012Curr OpinImmunol2012,24,2:1
14Targeting the PD-1/B7-H1 (PD-L1) pathway to activate anti-tumor immunity 显示文摘Topaiian SL Drake CG Pardoll DM 2012Curr Opin Immunol2012,24,2:1
15Targeting the PD1/B7-H1(PD-L1) pathway to activate anti-tumor immunity显示文摘Topalian SL Drake CG Pardoll DM 2012Curr Opin Immunol2012,24,2:1
16Targeting the PD-1/B7-H1 ( PD-L1 ) pathway to activate anti-tumor immunity 显示文摘Topalian SL Drake CG Pardoll DM 2012Curr Opin Immunol2012,24,2:1
17Immune checkpointblockade : A common denominator approach to cancer thera-py显示文摘Topalian SL Drake CG Pardoll DM 2015Cancer Cell2015,27,4:1
18Targeting the PD-1/ BT-HI(PD-L1) pathway to activate anti-tumor immunity 显示文摘Topalian SL Drake CG Pardoll DM 2012Curr Opin Immunol2012,24,2:1
19Targeting the PD-lIB7-HI ( PD-Ll) pathway to activate anti-tumor immunity显示文摘Topalian SL Drake CG Pardoll DM 2012CUIT Opin Immunol2012,24,2:1
20The addition of topical doxepin to corticoster oid therapy 显示文摘 Breneman SL Drake LA 1999International JournalofDermatolgy1999,389,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费